Journal of Diabetes Research and Clinical Metabolism

Journal of Diabetes Research and Clinical Metabolism

ISSN 2050-0866
Original Research

Pharmacokinetics of Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Glimepiride Following Co-administration in Healthy Volunteers: A Randomised, Open-label, Crossover Study

Sreeraj Macha1*, Michaela Mattheus2, Sabine Pinnetti3, Leo Seman1 and Hans J. Woerle2

*Corresponding author: Sreeraj Macha sreeraj.macha@boehringer-ingelheim.com

1. Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA


Journal of Diabetes Research and Clinical Metabolism  2012 1:14doi: 10.7243/2050-0866-1-14

No comments have yet been made on this article.
Volume 1
Full text Download
Order Reprints
View Metrics